Annual Total Long Term Liabilities
$5.29 M
+$217.30 K+4.28%
December 31, 2023
Summary
- As of February 21, 2025, ONCY annual total long term liabilities is $5.29 million, with the most recent change of +$217.30 thousand (+4.28%) on December 31, 2023.
- During the last 3 years, ONCY annual total long term liabilities has fallen by -$106.40 thousand (-1.97%).
- ONCY annual total long term liabilities is now -4.85% below its all-time high of $5.56 million, reached on December 31, 2021.
Performance
ONCY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$5.58 M
+$19.00 K+0.34%
September 30, 2024
Summary
- As of February 21, 2025, ONCY quarterly total long term liabilities is $5.58 million, with the most recent change of +$19.00 thousand (+0.34%) on September 30, 2024.
- Over the past year, ONCY quarterly long term liabilities has stayed the same.
- ONCY quarterly long term liabilities is now -15.54% below its all-time high of $6.61 million, reached on September 30, 2019.
Performance
ONCY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ONCY Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.3% | 0.0% |
| 3 y3 years | -2.0% | +10.0% |
| 5 y5 years | +23.1% | +10.0% |
ONCY Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.8% | +4.3% | -1.8% | +10.7% |
| 5 y | 5-year | -4.8% | +4.3% | -4.4% | +16.0% |
| alltime | all time | -4.8% | -100.0% | -15.5% | -100.0% |
Oncolytics Biotech Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.58 M(+0.3%) |
| Jun 2024 | - | $5.56 M(-2.1%) |
| Mar 2024 | - | $5.68 M(+7.4%) |
| Dec 2023 | $5.29 M(+4.3%) | $5.29 M(+2.0%) |
| Sep 2023 | - | $5.19 M(-2.8%) |
| Jun 2023 | - | $5.34 M(+1.6%) |
| Mar 2023 | - | $5.26 M(+3.6%) |
| Dec 2022 | $5.07 M(-8.8%) | $5.07 M(+0.6%) |
| Sep 2022 | - | $5.04 M(-6.1%) |
| Jun 2022 | - | $5.37 M(-4.3%) |
| Mar 2022 | - | $5.61 M(+0.9%) |
| Dec 2021 | $5.56 M(+3.0%) | $5.56 M(-1.1%) |
| Sep 2021 | - | $5.62 M(-3.7%) |
| Jun 2021 | - | $5.84 M(+3.8%) |
| Mar 2021 | - | $5.63 M(+4.2%) |
| Dec 2020 | $5.40 M(+2.2%) | $5.40 M(+4.5%) |
| Sep 2020 | - | $5.17 M(+4.6%) |
| Jun 2020 | - | $4.94 M(+2.7%) |
| Mar 2020 | - | $4.81 M(-8.9%) |
| Dec 2019 | $5.28 M(+22.8%) | $5.28 M(-20.1%) |
| Sep 2019 | - | $6.61 M(+23.1%) |
| Jun 2019 | - | $5.37 M(+15.2%) |
| Mar 2019 | - | $4.66 M(+8.4%) |
| Dec 2018 | $4.30 M(+16.6%) | $4.30 M(-5.2%) |
| Sep 2018 | - | $4.53 M(+3.6%) |
| Jun 2018 | - | $4.38 M(+7.6%) |
| Mar 2018 | - | $4.07 M(+10.4%) |
| Dec 2017 | $3.69 M(>+9900.0%) | $3.69 M(>+9900.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(-100.0%) |
| Dec 2006 | $128.60 K(-0.4%) | $128.60 K(-4.2%) |
| Sep 2006 | - | $134.30 K(0.0%) |
| Jun 2006 | - | $134.30 K(+4.6%) |
| Mar 2006 | - | $128.40 K(-0.5%) |
| Dec 2005 | $129.10 K(+3.4%) | $129.10 K(-13.8%) |
| Sep 2005 | - | $149.70 K(+22.3%) |
| Jun 2005 | - | $122.40 K(-1.2%) |
| Mar 2005 | - | $123.90 K(-0.7%) |
| Dec 2004 | $124.80 K(+8.1%) | $124.80 K(+5.0%) |
| Sep 2004 | - | $118.90 K(+5.7%) |
| Jun 2004 | - | $112.50 K(-1.7%) |
| Mar 2004 | - | $114.50 K(-0.9%) |
| Dec 2003 | $115.50 K(+21.6%) | $115.50 K(+4.0%) |
| Sep 2003 | - | $111.10 K(+0.5%) |
| Jun 2003 | - | $110.50 K(+8.4%) |
| Mar 2003 | - | $101.90 K(+7.3%) |
| Dec 2002 | $95.00 K(-81.0%) | $95.00 K(-51.9%) |
| Sep 2002 | - | $197.60 K(-37.3%) |
| Jun 2002 | - | $315.00 K(-20.9%) |
| Mar 2002 | - | $398.30 K(-20.2%) |
| Dec 2001 | $499.40 K(-34.2%) | $499.40 K(-25.4%) |
| Sep 2001 | - | $669.00 K(-5.9%) |
| Jun 2001 | - | $710.90 K(+0.7%) |
| Mar 2001 | - | $705.70 K(-6.9%) |
| Dec 2000 | $758.40 K(+634.9%) | $758.40 K(-6.5%) |
| Sep 2000 | - | $811.10 K(-5.0%) |
| Jun 2000 | - | $853.90 K(-1.9%) |
| Mar 2000 | - | $870.70 K |
| Dec 1999 | $103.20 K | - |
FAQ
- What is Oncolytics Biotech annual total long term liabilities?
- What is the all time high annual total long term liabilities for Oncolytics Biotech?
- What is Oncolytics Biotech annual total long term liabilities year-on-year change?
- What is Oncolytics Biotech quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly long term liabilities year-on-year change?
What is Oncolytics Biotech annual total long term liabilities?
The current annual total long term liabilities of ONCY is $5.29 M
What is the all time high annual total long term liabilities for Oncolytics Biotech?
Oncolytics Biotech all-time high annual total long term liabilities is $5.56 M
What is Oncolytics Biotech annual total long term liabilities year-on-year change?
Over the past year, ONCY annual total long term liabilities has changed by +$217.30 K (+4.28%)
What is Oncolytics Biotech quarterly total long term liabilities?
The current quarterly long term liabilities of ONCY is $5.58 M
What is the all time high quarterly long term liabilities for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly total long term liabilities is $6.61 M
What is Oncolytics Biotech quarterly long term liabilities year-on-year change?
Over the past year, ONCY quarterly total long term liabilities has changed by $0.00 (0.00%)